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Abstract
Background: Over the past 30 years, patients’ options for accessing information about prescription drugs have
expanded dramatically. In this narrative review, we address four questions: (1) What information sources are
patients exposed to, and are they paying attention? (2) Is the information they hear credible and accurate?
(3) When patients ask for a prescription, what do they really want and need? Finally, (4) How can physicians
reconcile what patients hear, want, and need?
Analysis: A critical synthesis of the literature is reported. Observations indicate that the public is generally aware of
and attends to a growing body of health information resources, including traditional news media, advertising, and
social networking. However, lay audiences often have no reliable way to assess the accuracy of health information
found in the media, on the Internet, or in direct-to-consumer advertising. This inability to assess the information
can lead to decision paralysis, with patients questioning what is known, what is knowable, and what their
physicians know. Many patients have specific expectations for the care they wish to receive and have little
difficulty making those expectations known. However, there are hazards in assuming that patients’ expressed
desires are direct reflections of their underlying wants or needs. In trying to reconcile patients’ wants and needs for
information about prescription medicines, a combination of policy and clinical initiatives may offer greater promise
than either approach alone.
Conclusions: Patients are bombarded by information about medicines. The problem is not a lack of information;
rather, it is knowing what information to trust. Making sure patients get the medications they need and are
prepared to take them safely requires a combination of policy and clinical interventions.
Background
Case presentation
John Doe is a 57-year-old man who has gained 30 pounds
over the past 10 years and recently noticed some numb-
ness in his toes. He seeks advice from his family physician.
The doctor orders some tests; the results are consistent
with adult-onset diabetes. At a follow-up appointment a
week later, the doctor recommends that Mr. Doe lose
weight and writes a prescription for metformin, widely
considered to be an effective first-line oral hypoglycemic.
Mr. Doe fills the prescription and returns home to
consider the implications of his diagnosis.
If this were 1975, the story might end there. Patients
interested in learning more about a newly diagnosed
condition would talk with family and friends. Some
might check out a newspaper, magazine, or tabloid or
visit the local bookstore or the library. The occasional,
highly motivated patient might dial up the health infor-
mation line at a local hospital or seek borrowing privi-
leges from the nearest academic medical center library.
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But since this is 2013, Mr. Doe has more options,
including the Internet, social media, and direct-to-
consumer advertising (DTCA) of prescription drugs and
other medical interventions.
After receiving the prescription for metformin, Mr. Doe
does another search on diabetes treatments and comes
across an online ad for Januvia® (sitagliptin). On reading
the ad, Mr. Doe concludes that Januvia has some real
advantages. He even starts to wonder why his doctor
failed to prescribe the very best medicine in the first
place. Maybe she isn’t keeping up, or maybe she’s just
trying to keep costs down. Mr. Doe picks up the phone
and makes another appointment to see her. He resolves
to ask for Januvia in the strongest possible terms.
This case raises several questions about the health
informational environment influencing patients’ attitudes
toward and use of prescription drugs. We focus on the
following four questions: (1) What information sources
are patients exposed to, and are they paying attention?
(2) Is the information they hear credible and accurate?
(3) When patients ask for a prescription, what do they
really want and need? Finally, (4) how can physicians
reconcile what patients hear, want, and need?
Analysis
This analysis takes the form of a critical, integrative synth-
esis of research from the fields of medicine, marketing,
public health, and health communication.
What sources of information about prescription
drugs are available to patients, and are they
paying attention?
Health information sources can be classified in various
ways. For example, Delorme et al. refer to interpersonal,
advertising, and mediated sources [1]. Interpersonal
sources include family, friends, and health professionals.
Advertising refers to overtly commercial messaging such
as DTCA of prescription drugs or drug-company Websites
[2-4]. Mediated sources include print and broadcast news,
entertainment programming, and the Internet. Social
media such as Facebook, Twitter, and online support
groups are sources of health information that occupy an
increasingly important middle ground between face-to-
face interpersonal and traditional media [5,6].
The health information environment is changing
rapidly. Some major newspapers are successfully shifting
their focus from print to the Internet, while others are
struggling to survive [7]. As newspapers contract, they
tend to lay off specialized health reporters trained to
sort through complex stories and place them in context
[8]. The same trends are evident in broadcast news,
where the number of health stories is increasing but the
average airtime per story is decreasing [9]. Meanwhile,
the Internet and DTCA offer abundant information, but
with little assurance against subtle bias, commercialism,
or deception. In short, while the public has greater
access to health information than ever, they are increas-
ingly vulnerable to potentially misleading information.
Although people differ in their health consciousness [10],
evidence suggests that many are aware of and responsive
to the health information environment. A Kaiser Family
Foundation survey of 42,000 Americans covering the per-
iod 1996–2002 showed that, overall, 4 in 10 adults follow
health news stories closely [11]. People appear to pay the
most attention to stories that are alarmist (“if it bleeds it
leads” [12]) or are personally relevant [13-15]. This may
explain why, in the Kaiser survey, public health hazards
and common diseases like cancer and Alzheimer’s disease
drew more attention from the public than specific prescrip-
tion drugs, which directly affect a small proportion of the
population (i.e., those who are taking the drugs or know
someone who is). Nevertheless, certain high-profile drug
stories have had considerable impact. For example, publi-
cation and subsequent media coverage of the Heart and
Estrogen/Progestin Replacement Study and the Women’s
Health Initiative were associated with significantly reduced
use of hormone replacement therapy in postmenopausal
women; at least part of the prescriber effect was likely
mediated through consumers [16].
The Internet has revolutionized health information
seeking in particular. Use of the Internet for health infor-
mation seeking is widespread and growing [4,5,17,18],
and such use often both precedes and follows medical
visits [19,20]. However, uneven uptake of new technolo-
gies raises equity concerns. For example, a Pew report
suggests that adults with chronic diseases (i.e., those
presumably most in need of the information) are less
likely to go online for health information than adults
reporting no chronic diseases (62% vs. 81%) [21]. While
this might be explained in part by age, other studies have
shown disparities in Internet health information seeking
between rich and poor, whites and minorities, and young
and old [22-25]. However, the socioeconomic digital
divide is shrinking, and some studies suggest that use of
mobile Internet platforms is greater among minorities
than among whites [26].
DTCA of medications has occurred since at least the
18th century [27], but DTCA of prescription drugs
accelerated in 1997 when the U.S. Food and Drug
Administration (FDA) relaxed its interpretation of stan-
dards limiting broadcast advertising [28]. Awareness of
DTCA among consumers is very high [3,29-31]. Survey
research and analyses of insurance claims suggest that
consumers notice prescription drug advertisements and
act on them by making additional physician visits,
requesting prescriptions, and occasionally registering
dissatisfaction when requested drugs are not provided
[2,32-35]. There is also evidence that drug manufacturers
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have successfully expanded the potential market for their
products by not only encouraging patients with chronic
conditions to stay on (adhere to) their medications but
also through “disease mongering” [36,37]; medicalizing
common symptoms such as mild depression [38] and leg
movements during sleep [39], and legitimizing contested
illnesses [40].
In summary, consumers are swimming in a sea of
health-related information, but paradoxically they may
still feel unprepared to participate in health-care deci-
sions [41]. Part of the problem is the paucity of com-
parative effectiveness data, a problem that may never be
fully resolved [42]. Another aspect of the problem is the
relative lack of patient-friendly materials addressing the
full spectrum of risks and benefits of treatment. Initiatives
launched by organizations like the American Medical
Association, the Cochrane Collaboration, the Society of
General Internal Medicine, and the Agency for Healthcare
Research and Quality are beginning to assemble patient-
friendly, integrated information for decision making, but a
comprehensive solution will likely require government
action.
Can patients trust what they see and hear?
The question of whether patients can trust what they
pick up from the health information environment is
inextricably bound to the question of whether they
should trust the information. In this brief analysis we
will distinguish credibility (whether patients subjectively
trust the information they hear about medications) from
accuracy (the degree to which the information merits
trust on the basis of medical evidence).
Consumer judgments regarding the credibility of
health information depend on characteristics of both the
source and the message. Evaluations of source credibility
derive from a person’s judgment of the information
source’s expertise (how much the person or organization
is thought to know) and trustworthiness (the degree to
which the source is believed to say what he or she
believes to be true) [43]. Such evaluations may depend
on personal knowledge of the source (e.g., “homophily”
or friendship, membership in the same social network
[44]), or on cues that signal reputational quality (e.g., a
report published by a well-known national organization
such as the Centers for Disease Control and Prevention
or the American Cancer Society). On the Internet, consu-
mers appear to take account of content comprehensive-
ness and Website complexity [45]. However, several
observational studies suggest that when evaluating online
health information, consumers have difficulty evaluating
source credibility [46].
In terms of message characteristics, studies have con-
firmed the importance of information quality, personali-
zation, impartiality, and richness of message features
(such as references and testimonials) [47,48]. However,
there may be critical interactions between patient charac-
teristics (e.g., their health numeracy skills) and evaluation
of message quality [49]; patients with poor quantitative
skills may become frustrated by too much numerical
information, whereas those with better skills and greater
sophistication may desire and expect more numerical
detail [50]. In fact, health literacy may determine to a
great extent whether patients understand medication-
related materials, including FDA warning labels [51].
Patients unable to attain a minimal threshold of under-
standing cannot be expected to extract benefit from such
materials, no matter how expertly written.
Regardless of what consumers may think, inaccurate
health information is common, even when reported by
well-known news outlets and reputable Websites [52].
Four phenomena threaten the trustworthiness of pre-
scription drug information as disseminated to the public.
First, the complex alliance of “Big Pharma,” government,
academic institutions, and medical journals is riddled by
problems including seeding trials (marketing campaigns
aimed at medical opinion leaders, disguised as clinical
trials), ghostwriting, and selective publication [53]. Sec-
ond, reporters frequently omit information about drug
company sponsorship of clinical trials and tend to col-
lude unintentionally with drug manufacturers by using
trade names rather than generic names. Reporting about
results presented at scientific meetings tends to be parti-
cularly intemperate [54,55]. Third, reporters often fail to
supply quantitative information, provide only relative
measures of impact, or misconstrue the meaning of
statistical significance [56]. Relative measures (e.g.,
“a 20% reduction in risk of death”) can be misleading if
not accompanied by base rates or absolute difference
measures (e.g., “a reduction in risk of death from 1% to
0.8%”). Similar errors of omission have been noted across
health Internet sites [17]. Fourth, as seen with the rota-
virus vaccine, there can be a tendency to overplay bene-
fits early in the life cycle of a product, followed by
sudden condemnation at the first sign of unanticipated
adverse effects [57]. The cacophonous and not wholly
trustworthy information environment is without doubt
one reason patients consistently report relying on physi-
cians and pharmacists for advice on medications [58].
A recent survey of patients suggests that those who have
relied upon medication information from the media,
brochures, family, and friends are less likely to adhere to
their treatment plans [59].
In contrast to news stories, the commercial origins of
DTCA are usually obvious. Nevertheless, consumers
often find these medication ads compelling, because the
ads engage their audience by appealing to emotions
[60,61] and by highlighting effectiveness, convenience,
symptom control, and innovativeness but not cost [62].
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However, the medication ads frequently do not address
critical issues, such as how to manage chronic conditions,
and they are formatted in ways that give low-literacy con-
sumers difficulty [63]. Quantitative data on effectiveness
are scarce [64]. When asked directly, many patients
report being skeptical of DTCA claims [65]. They have
good reason to be; the accuracy of information provided
about some therapeutic categories such as chemotherapy
is highly questionable [66]. Nonetheless, DTCA clearly
motivates patients to ask questions [67], request prescrip-
tions [68], and even seek drugs directly off the Internet;
one in five Americans report having asked their doctor
for a prescription based on a medication ad [69]. In addi-
tion, even skeptical persons may be susceptible to DTCA
over time, as the advertising claims become disassociated
with discredited sources (the “sleeper effect”) [70,71].
In summary, the public has no reliable way to assess
the accuracy of health information found in the print and
broadcast media, on the Internet, or in DTCA. This can
lead to decision paralysis, with many patients questioning
what is known and knowable and with a few even ques-
tioning what their physicians know.
What do patients really want and need?
Most patients seek formal medical care with a goal in
mind; they hope to gain answers to questions, relief of
symptoms, reassurance, or a specific intervention (e.g., a
test, a referral, or a prescription). When queried directly,
patients often report having highly specific expectations
for care. For example, one study performed in a general
internal medicine group practice showed that a majority
of patients wanted examinations of their head and neck,
lungs, heart, and abdomen in addition to blood testing;
but, an even larger group wished for counseling about
prognosis and discussion of the patient’s own ideas about
management [72]. A follow-up study of audio recordings
of 559 ambulatory visits showed that approximately one-
quarter of patients in primary care and cardiology made
observable requests for tests (8%), new medications
(11%), or specialty referrals (5%). Patients’ requests for
specialty consultations or medications independently
predicted whether they received those services [73].
When patients’ expectations are not fulfilled, they tend
to experience less improvement in health, have weaker
intentions to adhere to treatment, and report lower satis-
faction with the visit [74].
Do patients’ requests reflect their true underlying
desires? Two lines of evidence suggest not. First, in qua-
litative studies and survey research, patients consistently
emphasize the importance of interpersonal care, such as
the need for the physician to listen and provide informa-
tion [75]. In contrast, studies using direct observation
(audiotaping or videotaping) tend to document requests
for technical care (e.g., a prescription) or clinical infor-
mation (“what are the side effects of this medicine?”)
[73,76]. Evidently, and unsurprisingly, it is more difficult
to ask for a supportive relationship than for a computer-
ized tomography scan of the chest. In addition, even if
patients recognize their own needs, they do not always
voice them [77]. Second, in a follow-back interview
study of 125 patients with unmet expectations for care,
many patients assigned special significance to the ser-
vices they expected or requested. For example, 50% of
patients ascribed the genesis of their expectations for
physician interventions to perceived vulnerability (e.g.,
“My father had a heart attack at 40, and I’m 42—he
should at least listen to my heart!”) and 42% to past
experience with a similar illness (“My other doctor
always gave me antibiotics for this sore throat, and it
got better right away.”).
If patients cannot always get what they want, can
they at least get what they need? This begs the ques-
tion of how to define need, something that has fre-
quently vexed experts [78,79]. Without returning to
first principles, we suggest that patients need at least
three things from their doctors: valid evidence, clinical
discernment, and a healing relationship. Accurate
information is particularly important to highly engaged
patients in noncritical clinical situations, but even
patients with serious illnesses like cancer or amyo-
trophic lateral sclerosis value shared decision making
(up to one-third in some studies) [80]. Despite the
ready accessibility of information on medications,
patients still need help from their clinicians to identify
high-quality evidence and interpret it in light of their
own clinical circumstances. And research has consis-
tently upheld the importance to patients of clinicians
who listen carefully, communicate effectively, and con-
vey compassion and concern [81,82].
There are hazards in assuming that patients’ expressed
desires are direct reflections of their underlying wants
or needs. Simply acceding to patients’ requests for medi-
cations, for example, may have a number of potentially
deleterious consequences. For medicines with known
serious side effects or that are relatively new to the mar-
ket, providing an equivocally indicated prescription
places the patient at risk for adverse events without
countervailing benefit [83]. Some medicines may require
periodic monitoring with laboratory or imaging studies,
which themselves can trigger a “cascade effect” of false-
positive results that are followed by ever more invasive
testing [84]. Furthermore, focusing on the literal word-
ing of a request may distract attention from more signif-
icant underlying issues (e.g., fear of disease progression,
disability, disfigurement, or death), leading to a cycle of
anxiety and amplification of symptoms [85].
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How can conflicts between patients’ wants and
needs be reconciled?
In our increasingly chaotic health information environ-
ment, satisfying patients’ wants while ensuring that their
medication needs are met is a difficult challenge. We
suggest a combination of policy and individual-level
solutions.
Policy solutions should include interventions aimed at
improving the quality of the prescription drug information
available to consumers, improving the clarity of consu-
mer-directed signals that indicate reputational quality and
trustworthiness, and limiting the influence of commercial
bias in the production and dissemination of information
about medicines. The quality of prescription drug infor-
mation could be improved through a requirement that
consumer drug information include details on absolute
risks and benefits of therapy [86,87]; development of stan-
dards and training for news reporting of health-related
stories (possibly through organizations such as http://
healthjournalism.org) [88,89]; and arguably, formation of
an independent agency, funded in part by the pharmaceu-
tical industry, that would produce unbiased consumer
materials [90]. These efforts should take full advantage of
advances in our understanding of how people perceive
risks and how risk information can best be conveyed [91].
Better reputational signaling (at least on the Internet)
could be achieved through broader uptake of standards
such as those promulgated by the Health on the Internet
Foundation, which is a nongovernmental association
(http://www.hon.ch). The organization’s HONcode guide-
lines are now used by over 7300 Websites in more than
100 nations. Commercial bias could also be checked
through clinical trial registration; more transparency in
reporting conflicts of interest; and, arguably, a 2-year
moratorium on DTCA of new drugs [90].
These policy prescriptions would help, but their adop-
tion and implementation will take time. Meanwhile, clini-
cians see large numbers of patients everyday who are
caught up in a media and advertising frenzy that manufac-
tures new afflictions and urges “a pill for every ill” [92].
Prescription requests are common in office practice, and
physicians need to know how to respond. Our recommen-
dation is that the response be guided not just by the plain
language of the request, but by the physician’s interpre-
tation of the patient’s reasons for asking. While imple-
menting some of these recommendations may require the
investment of additional time in the beginning, they will
increase efficiency in the long run [93].
When patients talk about the genesis of their expecta-
tions for prescription medicines, they tend to emphasize
personal vulnerability and past experiences more than
the influence of specific news stories or DTCA [94]. A
request for medication is often a veiled request for under-
standing, empathy, concern, reassurance, or solidarity. The
prescription is a way of saying: “I take your concerns
seriously, and I am going to use my special powers as a
physician to address them.” Therefore, the physician’s first
step should be to clarify what patients really want. Instead
of interrupting within the first 18 to 21 seconds [95,96],
physicians should stop talking (or typing on the computer)
and allow patients to finish their opening statement [97],
which rarely takes more than 3 minutes. An occasional
“uh huh,” “something else?” or “anything else?” will facili-
tate disclosure of the patient’s full agenda. Once the
agenda is clear, the stage is set for a more productive clini-
cal negotiation [98].
Second, physicians should resist the temptation to pro-
vide encyclopedic quantities of information unless it is
clear that this is what the patient wants. It is easy to
assume that when patients ask questions or request inter-
ventions, they want specific facts or action; however, this
may or may not be the case. Patients will be more com-
fortable with the physician’s response if they are first
assured that their question was understood. Therefore,
when a patient asks for prescription medicine, the physi-
cian should respond with more questions: “How did you
hear about that medicine?” “How were you hoping it
would help you?” “Are you having any problems with the
medicine you’re already on?” When the physician under-
stands the underpinnings of the request, it is easier to
formulate a response that is both clinically appropriate
and mutually satisfying [99]. The physician may also con-
sider “prescribing” visits to Websites that offer unbiased
drug information, such as the U.S. National Library of
Medicine’s MedlinePlus® or http://ConsumerReports.org.
Third, physicians should be alert to patients’ emotional
clues. Work by Levinson et al. suggests that physicians
frequently miss opportunities to respond to patient emo-
tions such as frustration, anger, and despair [100]. These
cues are often conveyed nonverbally [101-103]. By
acknowledging patients’ distress, providing encourage-
ment, and offering support, physicians can help patients
overcome obstacles to effective self-care [100,104].
Fourth, physicians need to be aware of their own emo-
tions [105]. Patients’ requests for prescriptions can pro-
voke a spectrum of negative emotions in physicians,
including defensiveness, anger, anxiety, sadness, and
guilt. Awareness of these emotions can mitigate their
destructive consequences.
Finally, in negotiating with patients who seem to want
medicines that are not deemed in their best interest,
physicians have to give something to get something.
Three strategies have been widely adopted. The “substitu-
tion strategy” reframes the diagnosis (“The most likely
explanation for your fatigue is stress from work.”) or offers
an alternative therapeutic approach (“What we need to
do is get you on a regular exercise program.”) [99]. The
“contingency strategy” involves offering a therapeutic trial
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of the physician’s preferred therapy (or watchful waiting)
with the option to switch to the patient’s preferred treat-
ment after an agreed-on period of time without improve-
ment (“Here’s an antibiotic prescription, but don’t fill it
if you begin to see improvement before Wednesday.”)
[106]. In a closely related approach (the “availability strat-
egy”), the physician makes himself or herself available to
the patient as a bulwark against anxiety (“I’ll call you in
the morning on Thursday to make sure you’re doing
better.”). In a trial involving standardized patients portray-
ing depression, use of these strategies for “getting to
no” were associated with better subjective evaluations
of the physician when compared with simply rejecting
or ignoring the request [99].
Conclusions
Returning to the questions posed at the beginning of
this article:
• Patients are bombarded by information about medi-
cines. The problem is not a lack of information, it is
knowing what to trust.
• The quality of prescription drug information available
to consumers is variable, and consumers have difficulty
discriminating between reliable and less reliable sources
of information.
• When patients ask for medications, they may be
seeking something else entirely. It is the clinician’s job
to sort this out. This need not take much time.
• Making sure patients get the medications they need
and are prepared to take them safely requires a combi-
nation of policy and clinical interventions that also give
due consideration to nonpharmacologic treatments.
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